Introduction
Electrolytes that are present in the human body play an important role in many body processes, such as controlling fluid levels, acid-base balance (pH), nerve conduction, blood clotting and muscle contraction. Potassium, sodium and calcium are all important for proper electrolyte balance. Electrolyte imbalance resulting from kidney failure, dehydration, fever, and vomiting has been suggested as one of the contributing factors toward complications observed in diabetes and other endocrine disorders1. Diabetes mellitus is a heterogeneous group of metabolic disorder characterized by high blood glucose level (hyperglycemia) with alteration in carbohydrate, lipid, and protein metabolism resulting from defects in insulin secretion and/or action. Diabetes mellitus (DM) is rapidly emerging as an important cause of mortality and morbidity in developing countries2. The number of persons affected by diabetes continues to increase worldwide. Estimates suggest that 438 million individuals will be affected in 2030 3 by diabetes. The prevalence of diabetes is of great concern worldwide and 20% to 50% of new onset type II diabetes mellitus is observed in young generation4.
Diabetes Mellitus is an established risk factor for coronary heart disease (CHD), stroke, and end stage renal disease (ESRD). Diabetic nephropathy is one of the complications of diabetes mellitus, which ultimately leads to renal Diabetic patients frequently develop a constellation of electrolyte disorders. These derangement results from insulin deficiency, hyperglycemia and hyperketonemia. Hyperglycemia sets the internal environment for osmotic diuresis while causing a dilutional effect on electrolyte concentrations.The osmotic effect of glucose results in decreased circulating blood volume and fluid shift from the intracellular spaces causing cellular dehydration. These disturbances are particularly common in decompensated diabetes, especially in the context of diabetic ketoacidosis or non ketotic hyperglycemic hyperosmolar syndrome.These patients are markedly sodium, magnesium and phosphate depleted. Diabetes mellitus is linked to both hypo and hyperkalemia and also hypo and hypercalcemia reflecting coexistence of hyperglycemia related mechanisms, which tend to change serum potassium and calcium to opposite directions. This article provides an overview of the electrolyte disturbances occurring in Diabetes and mechanisms underlying those disturbances.
failure and renal failure is a cause of electrolyte imbalance among hospitalized diabetic patients. Other causes are diarrhoea, vomiting, diuretic use and chronic laxative use5. Electrolyte imbalance is common in patients with diabetes, which could be the result of an altered distribution of electrolytes and it is related to hyperglycemia induced osmotic fluid shifts or of total-body deficits brought about by osmotic diuresis4. Complications from end organ injury and the therapies used in the management of diabetes may also contribute to electrolyte disturbances6. In diabetes mellitus, increased frequency of electrolyte abnormalities occur due to various pathophysiological factors such as nutritional status, gastrointestinal absorption capacity, co-existent of acid-base abnormalities, pharmacological agents, other comorbid diseases (mainly renal disease) or acute illness, alone or in combination, play a key role 7 . They are mainly encountered in hospital populations occurring in a broad spectrum of patients (from asymptomatic to critically ill) and being associated with increased morbidity and mortality 8, 9, 10 . The disturbances of electrolyte homeostasis are also frequently observed in community subjects.
This article provides an overview of the electrolyte disturbances occurring in DM and describes possible underlying mechanisms. This insight should pave the way for pathophysiology-directed therapy, possibly contributing to the avoidance of several deleterious effects associated with electrolyte disorders and their treatment.
Sodium
Hyponatremia is the most common electrolyte abnormality in clinical practice and is associated with increased morbidity and mortality 11, 12 . Even small decreases of serum sodium are associated with increased probability for adverse outcomes (cognitive impairment, falls, osteoporosis and fractures 13 . Decreased serum sodium levels are observed in diabetic patients due to numerous underlying pathogenetic mechanisms 7, 14 . Increases in plasma glucose can lead to changes in plasma sodium concentrations through several mechanisms 6 . The direct measurement of serum osmolarity (Posm) can differentiate between hypotonic hyponatremia (with decreased Psom) and hyponatremia associated with normal or even increased tonicity 15 . In fact, glucose is an osmotically active substance. Thus, in cases of marked hyperglycemia Psom is increased leading to movement of water out of cells and subsequently to a reduction of serum sodium levels (dilutional hyponatremia)6. In such cases the corrected, for the degree of hyperglycemia, sodium value should be calculated. Thus to obtain the "true" sodium levels in cases of extreme hyperglycemia, the addition of 2.4 mEq/L to the measured concentration for every 100 mg/dl increment in plasma glucose of above normal levels is required 16 . This corrected sodium level should be used during treatment of severe hyperglycemic states 17 . In patients with dilutional hyponatremia the treatment of hyperglycemia is usually followed by a normalization of serum sodium levels 14 . Hyponatremia can also develop if a patient with uncontrolled diabetes has marked hypertriglyceridemia, even when the sodium concentration in plasma water is normal: a phenomenon called pseudohyponatremia 18 . Diagnosis of pseudohyponatremia is necessary to avoid dangerous overtreatment. It should be mentioned that, this case does not produce any of the symptoms classically attributed to hyponatremia. Improvement in glycemic control is associated with a rapid decrease in serum triglycerides resulting in the correction of pseudohyponatremia, thus no treatment is required 14 . The most common cause of hypotonic hyponatremia in patients with diabetes is osmotic diuresis-induced hypovolemia 4 . The patients with diabetic ketoacidosis, the excretion of β-hydroxybutyrate and acetoacetate obligate urine sodium resulting in aggravation of hypovolemia19. Drugs are common causes of hyponatremia in individuals with diabetes 20. A number of drugs (mainly thiazides, in combination with SSRIs 21 ), the first generation sulfonylureas (such as tolbutamide and chlorpropamide) 14, 21 , NSAIDs, angiotensin converting enzyme inhibitors, rosiglitazone or even amlodipine 20 . Patients with central nervous system disorders, pulmonary disorders including lung infections, and malignancies may exhibit hyponatremia due to the syndrome of inappropriate antidiuresis 14, 15, [21] [22] [23] . Patients with diabetic nephropathy and chronic renal failure are very prone to the development of hyponatremia due to decreased water excretion. Additionally, diabetic patients with hyporeninemic hypoaldosteronism commonly exhibit exaggerated natriuresis leading to volume depletion induced increase in ADH secretion, decreased water excretion and mild hyponatremia associated with asymptomatic hyperkalemia, and hyperchloremic metabolic acidosis 24 . It has been suggested that the altered vasopressin regulation in diabetes mellitus, the increased insulin induced potentiation of vasopressin-induced aquaporin AQP-2 water channels expression and the absorption of water from the GI tract due to slower stomach emptying may play a role in the association between diabetes mellitus and decreased serum sodium levels 25, 26 . Taking into consideration the multifactorial origin of hyponatremia in most patients with diabetes a cause-specific treatment is required. Administration of insulin drives glucose and water into the cells, reverses the initial direction of water movement and results in an increment of serum sodium levels.
A) Non-hypotonic hyponatremia

Potassium
The causes of hypokalemia in diabetes include: (1) redistribution of potassium K + from the extracellular to the intracellular fluid compartment (shift hypokalemia due to insulin administration); (2) gastrointestinal loss of K + due to malabsorption syndromes (diabetesinduced motility disorders, bacterial overgrowth, chronic diarrheal states); and (3) renal loss of K + (due to osmotic diuresis and/or co-existent hypomagnesemia). Hypomagnesemia can cause hypokalemia possibly because a low intracellular Mg 2+ concentration activates the renal outer medullary K + channel to secrete it more 27 . Hypokalemia is associated with impaired insulin secretion and decreased peripheral glucose utilization resulting in carbohydrate intolerance and hyperglycemia 28 . Exogenous insulin can induce mild hypokalemia because it promotes the entry of K + into skeletal muscles and hepatic cells by increasing the activity of the Na + K + ATPase pump 29 . The increased secretion of epinephrine due to insulin-induced hypoglycemia may also play a contributory role 30 . The majority of patients with diabetic ketoacidosis (DKA) and HHS are markedly K + depleted. The average K + deficit is 3-5 mEq/kg, but it can exceed 10 mEq/kg in some cases 31, 32 . A number of factors contribute to the DKA and HHS-associated potassium depletion, including vomiting, increased renal losses due to the osmotic diuresis and ketoacid anion excretion, and the loss of K + from the cells due to glycogenolysis and proteolysis 31, 33 . Hyperglycemia increases serum osmolality resulting in movement of water out of cells. The loss of intracellular water leads to an increased intracellular K + concentration, favoring a gradient for K + to move out of the cells. Simultaneously, the friction forces between solvent (water) and solute can result in K + being carried along with water through the water pores in the cell membrane 33 . Insulin therapy lowers K + concentration driving K + into cells (both directly and indirectly by reversing hyperglycemia). The risk of hypokalemia-related complications is particularly higher in diabetic subjects who have hypertension, myocardial infarction/ischemia, or heart failure as comorbidities. In addition, since diabetic patients are frequently on diuretics, diureticassociated hypokalemia (as well as hypomagnesemia and hypophosphatemia) should be taken into account in this setting 14 .
Hyperkalemia can be caused by an increase in plasma tonicity that results from the redistribution of potassium from the intracellular space to the extracellular space 34 . In patients with type 2 diabetes, the insulin-mediated uptake of glucose is impaired, but the cellular uptake of potassium remains normal, a situation that is consistent with the divergence of intracellular pathways that follows activation of the insulin receptor 35 . The efflux of potassium from the cell is due to intracellular dehydration, which results from the osmotically induced, transcellular movement of water. This movement creates a favorable gradient for the efflux of potassium 36 . Examples of shift hyperkalemia in DM include acidosis (for each 0.1 fall in pH, potassium increases by approximately 0.4 mmol/l), insulin deficiency, hypertonicity, cell lysis (rhabdomyolysis), and drugs (eg,beta blockers). Reduced glomerular filtration of K + (due to acute kidney injury and chronic kidney disease) and many drugs that interfere with K+ excretion are associated with hyperkalemia. These include angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, renin inhibitors, beta blockers and potassium-sparing diuretics. Nevertheless, the most common causal factor of chronic hyperkalemia in diabetes is the reduced tubular secretion of K + due to the syndrome of hyporeninemic hypoaldosteronism 24 . Consequently, diabetic patients (especially the elderly) on medications known to interfere with K + homeostasis are at increased risk for hyperkalemia 37, 38 . In such cases, close K + monitoring is fully warranted 39 .
Calcium
Hypocalcemia is a potential complication of diabetic nephropathy in patients with the nephrotic syndrome, even if the glomerular filtration rate is well preserved.The nephrotic state leads to urinary loss of 25-hydroxyvitamin D3 and its carrier protein 40 . Alterations in the set point for parathyroid hormone release and circulating levels in patients with diabetes are reminiscent of those found in hypoparathyroidism, having the potential to exacerbate the tendency for the development of hypocalcemia 41, 42 . Hypomagnesemia can be a cause of hypocalcemia because magnesium deficiency can result in impaired release of and or skeletal and renal tubule resistance to the action of parathyroid hormone 43 . Vitamin D deficiency and frusemide administration may also play a role in the occurrence of hypocalcemia 44 . Patients with DM have an increased risk for development of acute renal failure due to volume depletion, sepsis, rhabdomyolysis and drugs (eg radiographic contrast media). In this setting severe hyperphosphatemia may occur when phosphorus cannot be excreted by the malfunctioning kidney either with or without increased cell catabolism, thus resulting in hypocalcemia 14 . Primary hyperparathyroidism should be considered in patients with diabetes who have hypercalcemia 45 . It also found in patients with volume depletion, which leads to the increased reabsorption of renal calcium 46 . Hyperparathyroidism is related to long-term insulin resistance and relative insulin insufficiency, leading to overt DM or deterioration of glycemic control of established DM 47, 48 . It is thought that an elevated intracellular free calcium concentration increases the requirement for insulin, resulting in hyperparathyroidism-mediated insulin resistance 47 . Diabetes patients should be evaluated for hypercalcemia given that untreated hyperparathyroidism is linked to hypertension 47, 49 . A decreased bone formation due to metabolic acidosis and an increased bone mineral dissolution and resorption due to severe insulin deficiency and metabolic acidosis may also play a role 50 .
Magnesium
Magnesium is an essential ion for human health, as it is involved in virtually every mechanism in the cell, including energy homeostasis, protein synthesis and DNA stability 51 . Hypomagnesemia is a frequent electrolyte disorder in diabetic patients 52 . In addition, hypomagnesemia may impair glucose disposal and contribute to cardiovascular disease, retinopathy, and nephropathy 53 .
The incidence of hypomagnesemia in patients with type 2 diabetes ranges widely, from 13.5% to 47.7%. These include poor dietary intake, glomerular hyperfiltration, altered insulin metabolism, diuretic administration and recurrent metabolic acidosis 52. Furthermore, insulin promotes net shift of Mg 2+ from extracellular to intracellular space and can contribute to hypomagnesemia 54, 55 . Proton-pump inhibitors impair the gastrointestinal absorption of magnesium 56 . In patients with diabetic ketoacidosis, the osmotic diuresis resulting from poor glycemic control may lead to renal magnesium wasting. However the administration of insulin and the correction of acidosis shift magnesium into cells, and increased adrenergic activity may contribute to intracellular shifts in magnesium 57 . Mg 2+ is essential for life being involved in numerous enzymatic reactions, including ATP use, cell membrane, ion channels and mitochondrial function, as well as protein synthesis. The most clinically significant consequences of hypomagnesemia are ascribed to alterations in the function of excitable membranes in nerve, muscle, and the cardiac conducting system. Moreover, low serum Mg 2+ levels can secondarily induce hypokalemia, hypocalcemia, and hypophosphatemia, potentially causing further derangements in neuromuscular and cardiovascular physiology. Hypomagnesemia has been implicated in various long-term complications of DM, such as hypertension, increased carotid wall thickness, coronary artery disease, dyslipidemia, diabetic retinopathy, neuropathy, ischemic stroke, and foot ulcerations 52 . Hypomagnesemia has also been linked to diabetic nephropathy (from microalbuminuria to advanced renal disease) 58, 59, 60 . It has been proposed that hypomagnesemia is a predictor of end-stage renal disease in patients with diabetic nephropathy 60, 61 .
Phosphate
Diabetic patients have underlying conditions that predispose to the development of hypophosphatemia. These include primary hyperthyroidism, vitamin D deficiency, malabsorption, and the use of diuretics (thiazides and furosemide) 62 . It is known that increased insulin levels promote the transport of both glucose and phosphate into the skeletal muscle and liver cells. However, in normal subjects the administration of insulin leads only to a slight decrement of serum phosphate levels. The risk of severe hypophosphatemia is increased in cases of underlying phosphate depletion 63, 64 . Decompensated DM with ketoacidosis associated with excessive phosphate loss due to osmotic diuresis. Despite phosphate depletion, the serum phosphate concentration at presentation is usually normal or even high because both insulin deficiency and metabolic acidosis cause a shift of phosphate out of cells 65 . Administration of insulin and fluids, and correction of ketoacisosis may reveal phosphate deficiency and cause a sharp decrease in plasma phosphate concentration due to intracellular shift 62 . Correction of hypophosphatemia may have adverse effects, such as hypocalcemia and hypomagnesemia 32, 62, 66 . Careful phosphate replacement is required in patients with severe hypophosphatemia of less than 1.0 mg/dl (0.32 mmol/l) and in patients who develop cardiac dysfunction, hemolytic anemia, or respiratory depression 32, 67, 68 .
Conclusion
Electrolyte abnormalities are common in diabetes patients and may be associated with increased morbidity and mortality. Electrolyte imbalance has a significant effect upon the risk of contracting many diseases. These disturbances are particularly common in decompensated diabetes, in the elderly as well as in the presence of renal impairment. Patients with diabetes mellitus may receive complex drug regimens some of which may be associated with electrolyte disorders. Discontinuation of these medications when possible, as well as strict control of glycemia are of paramount importance to prevent electrolyte abnormalities in diabetic patients. The successful management of these disorders can best be accomplished by elucidating the underlying pathophysiologic mechanisms.
Also early diagnosis, good glycemic control and dietary modification are usually enough for prevention and treating complications in diabetes mellitus.
